Skip to main content
. 2019 Jul 15;42(12):675–683. doi: 10.1177/0391398819863429

Table 2.

Mean time interval in months (±SD) and number of episodes (in parenthesis) between the initial surgical placement of AVF and the first and follow-up radiological investigations (invest.) in relation to various background diagnoses.

Surg. to 1st invest. (n = 174) Follow-up invest. (n = 348) Surg. to 1st PTA Follow-up PTA (n = 320) PTA, numbers (n = 484)
Glomerulonephritisa 24 ± 32 (28) 9 ± 16 (48) 46 ± 58 (26)bf 13 ± 19 (33)b 2.0 ± 1.2 (59)b
Diabetic nephropathyb 14 ± 25 (47) 7 ± 9 (110) 16 ± 23 (48)a 7 ± 9 (136)a, c 5.3 ± 5.3 (184)a, cf
Interstitial nephritisc 18 ± 18 (24) 8 ± 11 (55) 22 ± 20 (21)a 12 ± 12 (40)b 2.7 ± 1.7 (61)b
Hereditary diseased 23 ± 29 (18) 5 ± 7 (33) 23 ± 28 (16)a 8 ± 6 (16) 1.7 ± 0.8 (32)b
Hypertension, nephrosclerosise 16 ± 17 (38) 7 ± 8 (82) 19 ± 23 (37)a 10 ± 8 (80) 2.9 ± 2.0 (117)b
Other diagnosesf 17 ± 23 (19) 4 ± 7 (20) 15 ± 17 (16)a 10 ± 11 (15) 1.6 ± 0.8 (31)b

SD: standard deviation; AVF: arteriovenous fistula; PTA: percutaneous transluminal angioplasty; ANOVA: analysis of variance.

Data are also displayed for the mean time interval in months between the initial surgical placement of AVF and the first and follow-up episodes of PTA intervention. These data include all interventions at the same instance, for example, if three different stenoses were dilated at the same time, each dilatation was calculated as one separate event. Mean numbers of PTA/sessions (±SD) and total PTAs (in parenthesis) are also given. Data were generated with ANOVA.

a–f

Significant differences (p < 0.05) between groups.